Why the study?
What are the demographic and metabolic predictors of restenosis 6 months after successful percutaneous transluminal coronary angioplasty?
What are the demographic and metabolic predictors of restenosis 6 months after successful percutaneous transluminal coronary angioplasty?
Answers are grounded in this paper and cite their sources.
Diabetes mellitus, male gender, and low HDL-cholesterol are significant clinical and metabolic predictors of angiographic restenosis 6 months after successful PTCA.
OBJECTIVE: The major concern about percutaneous transluminal coronary angioplasty (PTCA) is the high incidence of restenosis. METHODS: Demographic, clinical and biochemical data were recorded 2 weeks prior to PTCA in 388 patients fulfilling the criteria for initial stenosis, successful PTCA, and angiographic follow-up after 6 months. Restenosis was evaluated by quantitative coronary angiography. RESULTS: Variables predictive of restenosis in univariate analysis were diabetes mellitus, male gender, and the levels of high density lipoprotein (HDL) cholesterol, apolipoprotein A1 (Apo A1) and thio-barbituric acid-reactive substances (TBARS). In trend analysis through quartiles TBARS and fasting glucose levels were significantly associated with restenosis (p = 0.016 and 0.044, respectively), whereas the negative predictivity of Apo A1 and HDL-cholesterol were of borderline significance. In multivariate analysis male gender and diabetes mellitus showed predictivity of significance, and a negative predictivity was also apparent for HDL-cholesterol. CONCLUSION: We conclude that diabetes mellitus, male gender, and low HDL-cholesterol are predictors of restenosis 6 months after PTCA. In addition, TBARS may be a marker for the development of restenosis after PTCA.
No takes yet. Share an insight, caveat, or question.
Michael Abdelnoor Odd Johansen (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: